Johnson & Johnson will pay the state of New York more than USD 230 million in a settlement.
According to the Centers for Disease Control and Prevention the settlement comes after a time when the opioid industry is facing over 3,000 lawsuits across the nation for its contribution to an outbreak of prescription and street opioid abuse that killed more than 800 thousand Americans in the last 20 years.
Attorney General Letitia James said on Saturday that the drugmaker has agreed to permanently end the manufacturing and distribution of opioids across New York and the rest of the nation.
James said that the settlement involved two prescription painkillers developed by a subsidiary and accounting for less than 1% of the market and that are no longer sold in the US.
The settlement is the latest development in the complicated universe of opioid-related lawsuits across the US.
Johnson & Johnson along with other distributors AmerisourceBergen, Cardinal Health and McKesson last year made publicly that they are offering a total of USD 26 billion over 18 years to settle all the cases they face.